This content is in French.
Chikungunya: the invisible epidemic
9 juillet 2025
#CHIKV #Vaccine #Epidemiology #GlobalHealth #TropicalDiseases
With the recent approval of the IXCHIQ (Valneva) and VIMKUNYA (Bavarian Nordic) vaccines, a new era begins in the fight against the chikungunya virus (CHIKV). Yet, the true extent of its global impact remains poorly understood, complicating decisions around vaccination strategy. This large-scale international modeling study assesses virus circulation across 180 countries and simulates the effectiveness of various vaccination campaigns.
A vaccine in the shadow of a forgotten virus
With the recent approval of the IXCHIQ (Valneva) and VIMKUNYA (Bavarian Nordic) vaccines, a new era begins in the fight against the chikungunya virus (CHIKV). Yet, the true extent of its global impact remains poorly understood, complicating decisions around vaccination strategy. This large-scale international modeling study assesses virus circulation across 180 countries and simulates the effectiveness of various vaccination campaigns.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
